Document Details
Form
Filing Date
Feb 16, 2024
Document Date
Feb 14, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Verve Therapeutics
Issuer
VERVE THERAPEUTICS, INC.
Filer
Ashe Andrew D.
